InnoCare Pharma Ltd. Class A

InnoCare Pharma Ltd. Class A

11.09
HKD
-0.18
(-1.60%)
52.93BMarket Cap
Apr 01Next Earn

Total Valuation

HKD

As of June 30, 2026, InnoCare Pharma Ltd. carries a market capitalization of 52.93B, placing it among publicly traded companies globally. Its enterprise value stands at 45.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap52.93B
Enterprise Value45.50B

Important Dates

InnoCare Pharma Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of June 30, 2026, InnoCare Pharma Ltd. has 4.46B shares outstanding.

Shares Outstanding4.46B

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio5.97
P/TBV Ratio5.99

Financial Position

As of June 30, 2026, InnoCare Pharma Ltd. maintains a current ratio of 4.19, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities.

Current Ratio4.19
Quick Ratio3.80
Debt / Equity24.73

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count1,259.00

Stock Price Statistics

HKD

As of the close on November 17, 2026, InnoCare Pharma Ltd.'s stock has declined approximately 25.02% over the past 52 weeks. The 50-day moving average sits at 13.08, while the 200-day moving average is 13.02.

52-Week Price Change-25.02%
50-Day Moving Average13.08
200-Day Moving Average13.02

Balance Sheet

HKD

As of June 30, 2026, InnoCare Pharma Ltd. holds 9.65B in cash and equivalents against 2.20B in total debt, resulting in a net debt position of -5.13B. Total book value stands at 8.87B, with working capital of 8.10B providing operational flexibility.

Cash & Cash Equivalents9.65B
Total Debt2.20B
Net Debt-5.13B
Equity (Book Value)8.87B
Book Value Per Share1.99
Working Capital8.10B